Ligand profile
AE8
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00955 — DNA gyrase subunit A
Identifiers
Database identifiers and provenance.
- Ligand ID
AE8- PDB
4bul- UniProt (similar protein)
Q99XG5- Target protein
- KP13_00955
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 101.7
- −1 ≤ LogP ≤ 5 1.16
- MW ≤ 500 Da 467.5
- LogP ≤ 5 1.16
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 101.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1c(ncc2c1OCCO2)CNC3CCN(CC3)C[C@@]4(CN5c6c4c(cnc6C=CC5=O)F)Oc1c(ncc2c1OCCO2)CNC3CCN(CC3)C[C@@]4(CN5c6c4c(cnc6C=CC5=O)F)O
InChI=1S/C24H26FN5O4/c25-17-11-28-18-1-2-21(31)30-14-24(32,22(17)23(18)30)13-29-5-3-15(4-6-29)26-10-16-9-19-20(12-27-16)34-8-7-33-19/h1-2,9,11-12,15,26,32H,3-8,10,13-14H2/t24-/m0/s1InChI=1S/C24H26FN5O4/c25-17-11-28-18-1-2-21(31)30-14-24(32,22(17)23(18)30)13-29-5-3-15(4-6-29)26-10-16-9-19-20(12-27-16)34-8-7-33-19/h1-2,9,11-12,15,26,32H,3-8,10,13-14H2/t24-/m0/s1
VJVBZXRLYHVXIQ-DEOSSOPVSA-NVJVBZXRLYHVXIQ-DEOSSOPVSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00521
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand AE8 →
- PDB RCSB structure 4bul →
- UniProt UniProt Q99XG5 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “AE8”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00955.
PDB 24
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 16
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).